New study on immunotherapy for bone cancer A study in mice tested the effectiveness of an oncolytic, or cancer-destroying, virus called Delta-24-ACT. The treatment group developed tumors more slowly and experienced fewer severe side effects than the controls. Baby steps!
A study in mice tested the effectiveness of an oncolytic, or cancer-destroying, virus called Delta-24-ACT. The treatment group developed…